ArticleScientific reports2021
Durable nanocomposite face masks with high particulate filtration and rapid inactivation of coronaviruses.
Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 41 citations in OpenAlex.
- Quantification and characterization of manufactured nanomaterials shed from face masks.Scientific reports · 2026Article
- Environmental factors and antimicrobial efficacy: the impact of temperature and humidity on material surfaces.Microbiology spectrum · 2025Article
- Take a (statistical) look at microbial motility: analytical assessment of the early-stage interaction betweenMaterials today. Bio · 2025Article
- Cu-ZnO Embedded in a Polydopamine Shell for the Generation of Antibacterial Surgical Face Masks.Molecules (Basel, Switzerland) · 2024Article
- Experimental and CFD analysis of fluid flow through nanofiber filter media.Scientific reports · 2024Article
- One-step silver coating of polypropylene surgical mask with antibacterial and antiviral properties.Heliyon · 2024Article
- Article
- Biogenic production of silver, zinc oxide, and cuprous oxide nanoparticles, and their impregnation into textiles with antiviral activity against SARS-CoV-2.Scientific reports · 2023Article
- Functional Fiber Membranes with Antibacterial Properties for Face Masks.Advanced fiber materials · 2023Article
- Advanced and Smart Textiles during and after the COVID-19 Pandemic: Issues, Challenges, and Innovations.Healthcare (Basel, Switzerland) · 2023Review
- Prospects of ZnS and ZnO as smart semiconductor materials in light-activated antimicrobial coatings for mitigation of severe acute respiratory syndrome coronavirus-2 infection.Materials today. Communications · 2023Article
- Highly efficient and durable antimicrobial nanocomposite textiles.Scientific reports · 2022Article
- Effectiveness of Silver Nanoparticles Deposited in Facemask Material for Neutralising Viruses.Nanomaterials (Basel, Switzerland) · 2022Article
- COVID-19 and the Importance of Being Prepared: A Multidisciplinary Strategy for the Discovery of Antivirals to Combat Pandemics.Biomedicines · 2022Article
- Review
- Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.Frontiers in bioengineering and biotechnology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
The COVID-19 pandemic presents a unique challenge to the healthcare community due to the high infectivity rate and need for effective personal protective equipment. Zinc oxide nanoparticles have shown promising antimicrobial properties and are recognized as a safe additive in many food and cosmetic products. This work presents a novel nanocomposite synthesis approach, which allows zinc oxide nanoparticles to be grown within textile and face mask materials, including melt-blown polypropylene and nylon-cotton. The resulting nanocomposite achieves greater than 3 log
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.